Introduction
============

Roux-en-Y gastric bypass (RYGB) is an effective treatment for morbid obesity as well as type 2 diabetes ([@bib8]). Diabetes remission is achieved within days of RYGB and before significant weight loss has been achieved ([@bib4]; [@bib46]). Factors that have been proposed to contribute to the metabolic improvements following RYGB include calorie restriction ([@bib20]), increased postprandial release of glucagon-like peptide 1 ([@bib28]), enhanced circulating levels of bile acids ([@bib45]) and alterations in the metabolome ([@bib36]; [@bib14]; [@bib2]). In addition, RYGB has been shown to induce marked shifts in the intestinal microbiota in rodents ([@bib31]; [@bib33]) and humans ([@bib53]; [@bib24]; [@bib15]; [@bib48]). However, it is not clear whether these alterations in the microbiota contribute to the improvement of glucose metabolism associated with RYGB.

Duodenal jejunal bypass (DJB) is a stomach-sparing surgical procedure resulting in an intestinal configuration similar to that following RYGB ([Figure 1a](#fig1){ref-type="fig"}). DJB has been demonstrated to improve glucose tolerance in nonobese diabetic Goto-Kakizaki rats ([@bib40]; [@bib22]; [@bib47]), although one study did not observe any improvement ([@bib13]). DJB has also been reported to promote mild improvements in glucose tolerance in overweight humans ([@bib9]; [@bib23]). However, it is not known how this procedure affects the gut microbiota.

Fa/fa rats are leptin receptor-deficient rats that develop impaired glucose tolerance with age ([@bib19]). Earlier studies in fa/fa rats have reported that RYGB promotes pronounced weight loss and reduces glucose and insulin levels ([@bib51]) and DJB improves glucose tolerance ([@bib41]; [@bib30]; [@bib38]). Thus, fa/fa rats represent an attractive animal model to study surgery-induced physiological improvements ([@bib16]; [@bib50]; [@bib32]). Little is known about how the gut microbiota is linked to these changes in fa/fa rats, but a recent study reported that age and microenvironment affect the fecal microbiome in these rats ([@bib29]). Here, we studied the gut microbiota of fa/fa rats along the length of the intestine and investigated the following: (i) how the microbiota varies between diabetic fa/fa rats and nondiabetic fa/+ rats along the length of the intestine; (ii) whether changes in the gut microbiota in fa/fa rats can be normalized by RYGB and/or DJB; and (iii) how the altered microbiota from different locations in the intestine contributes to glucose metabolism.

Materials and methods
=====================

Surgically treated rats
-----------------------

The five groups of rats used in the surgery experiments (fa/+, fa/fa, sham-operated fa/fa, RYGB-treated fa/fa and DJB-treated fa/fa rats) have been described in an earlier study to assess differences in glycemic control ([@bib44]). Briefly, male fa/+ and fa/fa rats were purchased from Charles River, Lyon, France, at 6 weeks of age and were individually housed under ambient humidity at 22 °C in a 12 h light/dark cycle. The rats had free access to drinking water and Purina Lab diet (Lab diet, St Louis, MO, USA, 16.7% of calories from fat). At 12 weeks of age, fa/fa rats were randomly allocated to an unoperated control group or to sham, RYGB or DJB surgery groups, and surgery was performed as described earlier ([@bib44]). All experiments were approved by the Veterinary Office of the Canton Zurich, Switzerland.

Duodenal, jejunal and ileal contents from fa/+, fa/fa and sham-operated groups and contents from corresponding segments (that is, biliopancreatic, alimentary and common channel limbs) of RYGB- and DJB-treated fa/fa rats ([Figure 1a](#fig1){ref-type="fig"}) were collected on day 35 after surgery and snap frozen in liquid nitrogen immediately. Colon and cecal contents from all the groups were excised and snap frozen.

Ileal and cecal transplants
---------------------------

Germ-free Swiss Webster male mice aged 10 weeks were used for all transplantation experiments ([Figure 1b](#fig1){ref-type="fig"}). Frozen contents from the ileum and cecum of sham- and RYGB-operated fa/fa rats were homogenized in phosphate-buffered saline buffer supplemented with reducing solution (0.02 [m]{.smallcaps} Na~2~S and 1% cystein dissolved in NaHCO~3~ buffer). Two separate donors from each group were selected. Germ-free mice (four to five mice per group) were fasted for 4 h and gavaged with the resultant slurry (200 μl). The transplanted mice were maintained in autoclaved individual ventilated cages with sterile bedding and fed autoclaved food and water *ad libitum* for 2 weeks. Whole-body magnetic resonance imaging was performed on day 1 and day 14 after the transplantation. On day 14, an oral glucose tolerance test (OGTT) was performed in mice by oral administration of 30% [d]{.smallcaps}-glucose (2 g kg^−1^ body weight) after a 4 h fast. Blood was drawn from the tail vein at 0, 15, 30, 60, 90 and 120 min, and blood glucose levels were measured with a Bayer glucometer. The ileum and cecum from colonized mice were collected and snap frozen in liquid nitrogen and stored at −80 °C until further process. These procedures were approved by the Ethics Committee on Animal Care and Use in Gothenburg, Sweden.

Gut microbiota analysis
-----------------------

DNA was extracted from all the rat samples using repeated bead-beating protocol as described previously ([@bib43]), and the V1--V2 region of bacterial 16S rRNA gene was amplified using the 27 F and barcoded 338 R primers fused with 454 Titanium sequencing adaptors ([@bib18]). Three independent 25 μl PCR reactions were performed for each sample under the following conditions: one cycle: 3 min at 95 °C; 30 cycles: 20 s at 95 °C, 30 s at 52 °C, and 60 s at 72 °C and 10 min at 72 °C. The resulting product was checked for size and purity on 1% agarose gel, further purified (NucleoSpin 740609, Macherey-Nagel, Düren, Germany), and quantified with the Quant-iT PicoGreen dsDNA kit (Invitrogen, Carlsbad, CA, USA). Low-yield samples were speed vacuumed to concentrate DNA. All the samples were pooled in equal amounts (20 ng μl^−1^) and purified again with magnetic beads (AMPure XP, Beckman, Danvers, MA, USA) to remove short amplification products. The purified amplicons were sequenced in a 454 GS FLX system with Titanium chemistry by GATC Biotech (Konstanz, Germany). Two samples with low sequences were excluded from analysis.

DNA was extracted from the mouse samples by the same protocol as above. The V4 region of the 16S rRNA gene was amplified using 515 F and 806 R primers designed for dual indexing ([@bib25]), 10 ng μl^−1^ samples were pooled (with the same purification steps) and the Illumina MiSeq (Illumina RTA v1.17.28; MCS v2.5) platform was used for the analysis.

Quality-filtered 454 pyrosequencing and Illumina reads from both experiments were analyzed using the QIIME (Quantitative Insights Into Microbial Ecology) software package ([@bib6]; version 1.9.1) as described previously ([@bib5]). Briefly, chimeric sequences were identified with ChimeraSlayer ([@bib17]) and excluded from all downstream analyses. The sequences were clustered into operational taxonomic units (OTUs) at a 97% identity threshold using a closed-reference OTU picking approach with UCLUST ([@bib11]) against the Greengenes reference database ([@bib10]). Representative OTUs were aligned using PyNAST ([@bib7]) and used to build a phylogenetic tree which was used to estimate α-, and β-diversity of samples using unweighted UniFrac ([@bib34]). Sequences that could not be aligned with PyNAST and singletons were excluded. To correct for differences in sequencing depth, the same number of sequences were randomly sub-sampled for each sample and used for diversity analyses. Statistical significance of sample groupings was tested with a multivariate nonparametric analysis of variance (Adonis, 999 permutations; [@bib1]). Sequence data from the rat and mice analyses are stored in the European Nucleotide Archive ([www.ebi.ac.uk/ena](http://www.ebi.ac.uk/ena)) under accession numbers PRJEB20172 and PRJEB20197, respectively.

The online source BLAST was used to identify V1--V2 sequences at the species level for the most abundant and significant OTUs that had not already been specified in the OTU table.

Statistical analysis
--------------------

Data are presented as mean±s.e.m. OTUs (at six taxonomic levels, from phylum to species level) differing between groups were identified in QIIME with the nonparametric Kruskal--Wallis test. To determine the differences between groups (which were not reported in QIIME), the OTUs that had a *P*-value \<0.05 (with false discovery rate correction) in the QIIME analysis were thereafter analyzed with Kruskal--Wallis test with Dunn's multiple comparison to determine pair-wise differences using GraphPad prism version 6 (GraphPad Software Inc.) as reported previously ([@bib12]). Statistical comparison of two groups was performed by the nonparametric Mann--Whitney *U*-test. Significance was established at *P*\<0.05.

Results
=======

Composition of the gut microbiota of fa/fa rats is modified by RYGB but not by DJB
----------------------------------------------------------------------------------

Fasting glucose and insulin levels in the five groups of rats used in this study (unoperated fa/+, unoperated fa/fa, sham-operated fa/fa, RYGB-treated fa/fa and DJB-treated fa/fa) have previously been reported: both variables were significantly higher in unoperated fa/fa rats compared with fa/+ rats at 17 weeks of age and were normalized in fa/fa rats that underwent RYGB but not in those that were sham operated ([@bib44]). There was a small reduction in fasting blood glucose levels in DJB-treated fa/fa rats compared with sham-operated rats, but levels remained significantly higher than those in RYGB-treated rats ([@bib44]). Body weight was similar in all groups of mice at 17 weeks of age except for the RYGB-treated group in which body weight was significantly lower ([@bib44]).

To determine whether these differences between the groups of rats were associated with changes in the microbiota along the length of the gut, we performed 454 sequencing on samples collected from the duodenum, jejunum, ileum and colon of these rats. In total, we generated 566521 reads averaging 5665±2086 reads per sample. Alpha diversity (as measured by the observed species) did not differ between fa/fa and fa/+ rats nor between DJB-treated rats and sham-operated rats but was significantly higher in the ileum of RYGB-treated rats compared with sham-operated rats ([Figure 2a](#fig2){ref-type="fig"}). Unweighted UniFrac analysis (sensitive to the phylogenetic relatedness of taxa) on all the samples revealed significant clustering by intestinal segment (Adonis: *R*^2^=0.12, *P*=0.001; [Figure 2b](#fig2){ref-type="fig"}). This analysis also showed that surgery could explain more variability in the microbiota composition (Adonis: *R*^2^=0.42, *P*=0.001) than intestinal segment; in particular, RYGB samples formed a separate cluster ([Figure 2c](#fig2){ref-type="fig"}). The non-phylogenetic Bray--Curtis analysis showed similar results ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). We also performed unweighted UniFrac analysis on the samples divided according to intestinal segment and observed significant clustering of samples from RYGB-treated fa/fa rats in the duodenum (Adonis: *R*^2^=0.28, *P*=0.001), jejunum (Adonis: *R*^2^=0.34, *P*=0.001), ileum (Adonis: *R*^2^=0.41, *P*=0.001) and colon (Adonis: *R*^2^=0.31, *P*=0.001; [Figure 2d](#fig2){ref-type="fig"}).

Firmicutes was the most abundant phylum in the small intestinal regions of unoperated fa/+ rats, and increased in abundance in unoperated fa/fa rats to 98% of the total microbial composition in the jejunum and ileum ([Figure 3a](#fig3){ref-type="fig"}). The levels of Firmicutes were not affected by DJB compared with sham surgery in the small intestine of fa/fa rats, but were significantly lower in fa/fa rats after RYGB versus sham in the ileum ([Figure 3a](#fig3){ref-type="fig"}). Bacteroidetes was the second-most abundant phylum in the small intestinal regions of unoperated fa/+ rats and it showed a trend towards lower abundance in the duodenum, jejunum and ileum of unoperated fa/fa compared with fa/+ rats ([Figure 3a](#fig3){ref-type="fig"}). The levels of Bacteroidetes were not affected by DJB compared with sham surgery in the jejunum and ileum of fa/fa rats, but were significantly higher in fa/fa rats after RYGB versus sham in the ileum ([Figure 3a](#fig3){ref-type="fig"}). The abundance of the phylum Proteobacteria was significantly higher in the jejunum of unoperated fa/+ rats and RYGB-treated fa/fa rats compared with sham-operated fa/fa rats ([Figure 3a](#fig3){ref-type="fig"}).

By comparing the relative abundance of genera across the five groups of rats and along the length of the intestine, we showed that *Lactobacillus* was the predominant genus in all the intestinal regions in unoperated fa/fa, and sham-operated and DJB-treated rats ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). By contrast, *Lactococcus* was the most abundant genus in RYGB-treated rats in all the intestinal regions ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}).

[Supplementary Table S1](#sup1){ref-type="supplementary-material"} shows the taxa that significantly differed in abundance in unoperated fa/+ rats and RYGB-treated fa/fa rats compared with sham-operated fa/fa rats. Using this information, we focused on the most abundant bacterial species from the three most predominant phyla to identify key species that could potentially contribute to the observed differences in phenotype between the groups of rats. The taxa in [Supplementary Table S1](#sup1){ref-type="supplementary-material"} included OTUs that had not earlier been identified at the species level, and we used BLAST to identify the most abundant OTUs within Firmicutes, Bacteroidetes and Proteobacteria at the species level. Thus, OTU 189681 was identified as *Lactobacillus animalis* (max score =2169, total score =2169, query cover =100%, identity =94%, *E*-value =0.0); OTU 199716 was identified as *Bacteroides vulgatus* (max score =2128, total score =14 827, query cover =100%, identity =94%, *E*-value =0.0); and OTU 1109362 was identified as *Escherichia coli* (max score =2525, total score =17 379, query cover =100%, identity =97%, *E*-value =0.0).

Within Firmicutes, the most abundant species that differed across the groups of rats were *L. animalis, Lactobacillus reuteri* and *Lactococcus* sp. ([Figures 3b--d](#fig3){ref-type="fig"}). Both *L. animalis* and *L. reuteri* showed a similar pattern in all the intestinal segments investigated, with increased abundance in sham-operated fa/fa rats compared with unoperated fa/+ rats, no difference between DJB-treated and sham-operated fa/fa rats, and significant reductions in RYGB-treated compared with sham-operated fa/fa rats ([Figures 3b and c](#fig3){ref-type="fig"}). *Lactococcus* sp. also showed a similar pattern in all the intestinal segments investigated, but its abundance was dramatically reduced in sham-operated fa/fa rats compared with unoperated fa/+ rats, not affected by DJB compared with sham surgery, and dramatically increased in RYGB-treated compared with sham-operated fa/fa rats ([Figure 3d](#fig3){ref-type="fig"}).

Within Bacteroidetes, the most abundant species that differed across the groups of rats were *B. vulgatus* and *Bacteroides acdifaciens* ([Figures 3e and f](#fig3){ref-type="fig"}). The abundance of these species was reduced in sham-operated fa/fa rats compared with unoperated fa/+ rats in the duodenum, not affected by DJB compared with sham surgery and increased in RYGB-treated compared with sham-operated fa/fa rats, and the differences were most pronounced in ileum ([Figures 3e and f](#fig3){ref-type="fig"}). Among Proteobacteria, *E. coli* also increased in the jejunum, ileum and colon in RYGB-treated compared with sham-operated fa/fa rats ([Figure 3g](#fig3){ref-type="fig"}).

Thus, RYGB surgery in fa/fa rats promoted changes in the microbial composition along the length of the intestine, in particular, a dramatic reduction in the abundance of *Lactobacillus* species and an increase in *Bacteroides* species, resulting in a microbiota composition similar to that of unoperated nondiabetic fa/+ rats. These changes (compared with sham surgery) were not observed following DJB in fa/fa rats.

Transplanting the ileal microbiota does not transfer the metabolic phenotype of fa/fa rats
------------------------------------------------------------------------------------------

As RYGB had the largest effect on the microbiota in the ileum, we transferred the ileal microbiota of sham- and RYGB-operated fa/fa rats to germ-free mice to investigate whether the ileal microbiota directly contributes to the metabolic phenotype of these rats. Alpha diversity was lower in the cecum of germ-free mice that received ileal microbiota from sham-operated rats (termed 'sham recipients') compared with germ-free mice that received ileal microbiota from RYGB-treated rats (termed 'RYGB recipients' [Figure 4a](#fig4){ref-type="fig"}). Unweighted UniFrac analysis showed separation of sham and RYGB recipients along the first principal component (Adonis: *R*^2^=0.37, *P*=0.001, [Figure 4b](#fig4){ref-type="fig"}), indicating that the donor ileal microbiota determines the microbiota composition of the recipient.

Despite the lower microbial diversity in the recipients of sham compared with RYGB ileal microbiota, levels of colonization (that is, total bacteria) were similar in both the groups ([Figure 4c](#fig4){ref-type="fig"}), with higher bacterial load in the cecum compared with the ileum. Glucose tolerance (in response to an OGTT) was impaired and fat gain was higher in the RYGB recipients compared with the sham recipients ([Figures 4d and e](#fig4){ref-type="fig"}).

Transplanting the cecal microbiota transfers the metabolic phenotype of fa/fa rats
----------------------------------------------------------------------------------

To investigate whether the microbiota in the cecum, which has a higher biomass and is more metabolically active compared with the ileal microbiota, of fa/fa rats directly contributes to the metabolic phenotype of these rats, we transplanted the cecal microbiota of sham- and RYGB-operated fa/fa rats into germ-free mice and colonized the mice for 2 weeks.

Alpha diversity was lower in the cecum of recipients of cecal microbiota from sham- versus RYGB-operated fa/fa rats ([Figure 5a](#fig5){ref-type="fig"}). Unweighted UniFrac analysis confirmed that samples clustered according to the type of donor microbiota (Adonis: *R*^2^=0.38, *P*=0.001, [Figure 5b](#fig5){ref-type="fig"}).

There were no differences in the total levels of bacteria in the ileum or cecum of sham versus RYGB recipient mice ([Figure 5c](#fig5){ref-type="fig"}). However, the peak glucose concentration in the OGTT was higher in the sham recipients than in the RYGB recipients, indicating improved glucose tolerance in the RYGB recipients ([Figure 5d](#fig5){ref-type="fig"}). Adiposity in sham and RYGB recipients 2 weeks after transplantation was similar ([Figure 5e](#fig5){ref-type="fig"}).

Discussion
==========

We previously investigated the effect of surgery on glycemic control in diabetic fa/fa rats and showed that (i) RYGB produces significant weight loss and improved fasting glucose levels compared with sham surgery; and (ii) DJB produces mild improvements in fasting blood glucose without weight loss ([@bib44]). Here we studied the microbiota composition of these rats along the length of the intestine to investigate potential associations between the microbiota and glycemic control. First, we showed an expansion of Firmicutes and reduction in Bacteroidetes in the jejunum and ileum of fa/fa rats compared with nondiabetic fa/+ rats. Second, we observed that RYGB, but not DJB surgery, in fa/fa rats promoted changes in the microbial composition along the length of the intestine; in particular, a dramatic reduction in the abundance of *Lactobacillus* species (including *L. reuteri* and *L. animalis*) and an increase in *Lactococcus* and *Bacteroides* species, resulting in a microbiota composition similar to that of unoperated nondiabetic fa/+ rats. Finally, by microbiota transfer to germ-free mice, colonization with the cecal, but not the ileal, microbiota of RYGB-treated fa/fa rats partially transferred the phenotype of improved glycemic control to recipient mice.

An association between *Lactobacillus* species and blood glucose levels has previously been noted in humans. For example, an increased abundance of *Lactobacillus* species has been reported in both European ([@bib21]; [@bib35]) and Chinese ([@bib27]; [@bib39]) patients with type 2 diabetes, and fecal *Lactobacillus* levels were shown to correlate with blood glucose levels in a study of men with varying degrees of glucose tolerance ([@bib26]). However, it is not known whether *Lactobacillus* contributes to type 2 diabetes or increases merely as a consequence of the disease. Indeed, *Lactobacillus* species are used as probiotics and have been shown to improve glucose levels in mice ([@bib52]).

Although the intestinal configuration following RYGB and DJB is similar ([Figure 1](#fig1){ref-type="fig"}), DJB did not affect the microbiota composition compared with sham. Microbiota changes in response to RYGB are likely to be produced by reduced calorie intake, changes in luminal pH and an early arrival of undigested food in the alimentary limb. RYGB is also accompanied by increased expression of glucose transporter 1 in rats ([@bib42]) and humans ([@bib37]), which facilitates increased glucose uptake in the alimentary limb thus reducing simple sugars in the intestinal lumen, which may explain the reduced levels of *Lactobacillus*. By contrast, DJB is a stomach-sparing procedure, and thus gastric juices, stomach size in addition to calorie intake are likely important factors in shaping the gut microbiota.

The important contribution of a microbiota to metabolic phenotype was first shown in germ-free C57/BL6 mice that gained 57% of fat and exhibited impaired glucose tolerance after 2 weeks of colonization with cecal microbiota from a conventionally raised mouse ([@bib3]), likely due to the extra energy provided by utilization of indigestible carbohydrates by a complex gut microbiota. More recent studies have shown that metabolic phenotypes can be transferred by transplanting the microbiota. For example, a reduction in adiposity after RYGB can be transferred by transplanting cecal contents from RYGB-treated mice ([@bib33]) or feces from RYGB-operated humans ([@bib48]) into germ-free mice; however, these studies did not report an effect of microbiota transfer on glucose tolerance. Although a causal relationship between altered gut microbiota and improved glucose control after RYGB is uncertain in humans, it has been reported that fecal transplant from lean donors to men with metabolic syndrome improved insulin sensitivity and increased populations of butyrate-producing intestinal bacteria ([@bib49]).

In our study, the differences between the microbiota of sham- versus RYGB-treated fa/fa rats were higher in the ileum than in the colon, and we therefore speculated that the difference in metabolic phenotype between these groups could be transferred by transplanting the ileal microbiota. However, we showed that colonization of germ-free mice with ileal microbiota from sham-operated rats resulted in less fat gain and improved glucose tolerance compared with recipients of ileal microbiota from RYGB-treated rats. This could potentially be explained by the lower diversity in sham versus RYGB donor ileal microbiota, a phenotype that was transferred to recipients. Microbiota with low bacterial diversity may be less adapted to metabolize complex carbohydrates resulting in lower fat gain and improved glucose tolerance.

In contrast to mice colonized with ileal microbiota, mice colonized with cecal microbiota from sham-operated rats showed worse glucose tolerance compared with recipients of cecal microbiota from RYGB-treated rats. Although microbial diversity was lower in the cecum of recipients of cecal microbiota from sham- versus RYGB-operated rats, it was not as low as in the recipients of ileal microbiota from sham-operated rats. Thus, bacterial diversity may not be a limiting factor in the cecal transfer experiments. These results suggest that differences in cecal microbiota composition between the sham- versus RYGB-operated rats could contribute to the improved metabolic phenotype of RYGB-operated rats.

Taken together, our results showed that the microbiota composition of diabetic fa/fa rats along the length of intestine was significantly altered by RYGB but not by DJB, and resembled the microbiota composition of fa/+ rats. Importantly, we also showed that RYGB-induced effects on the cecal microbiota partly contributed to improved glucose tolerance.
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![Schematic of experimental design. (**a**) Five groups of rats were used: unoperated fa/+ and fa/fa rats, and sham-operated, RYGB- and DJB-treated fa/fa rats. In the sham group, gastrotomy on anterior wall of stomach and jejunostomy was performed with no reconfiguration of the gut. Intestinal segments were collected for microbiota sequencing. (**b**) Ileum and cecum from sham and RYGB rats (two donors each) were transferred to germ-free recipients (*n*=4--5 per donor). Magnetic resonance imaging (MRI) was performed 1 and 14 days after transplantation. An oral glucose tolerance test (OGTT) was performed and ileum and cecum from each recipient were collected for microbiota sequencing 14 days after transplantation.](ismej201770f1){#fig1}

![Bacterial diversity along the length of intestine in unoperated and operated fa/fa rats. (**a**) Diversity box plots obtained from alpha rarefaction measured by observed species. Data are shown as box and whiskers plots, indicating the median (thick line in the box), the 25th--75th percentile range (boxes), and the 1st--99th percentile range (whiskers). \**P*\<0.05 versus sham in ileum. Principal coordinate analysis (PCoA) plot using unweighted UniFrac distances of gut microbial communities separated either by (**b**) intestinal segment; (**c**) surgery; or (**d**) as in **c**, but divided according to intestinal segment in fa/+ (*n*=4--5), fa/fa (*n*=4--5), sham-operated fa/fa (*n*=5), DJB-treated fa/fa (*n*=5) and RYGB-treated fa/fa (*n*=5--6) rats. The first three prinicipal coordinates from PCoA are plotted. Symbols represent data from individual rats.](ismej201770f2){#fig2}

![Microbial community shifts along the length of intestine in unoperated and operated fa/fa rats. Relative abundance of (**a**) major phyla, (**b**) *Lactobacillus animalis*, (**c**) *Lactobacillus reuteri*, (**d**) *Lactococcus* sp., (**e**) *Bacteroides vulgatus*, (**f**) *Bacteroides acidifaciens* and (**g**) *Escherichia coli* in duodenum, jejunum, ileum and colon of fa/+ (*n*=4--5), fa/fa (*n*=4--5), sham-operated fa/fa (*n*=5), DJB-treated fa/fa (*n*=5) and RYGB-treated fa/fa (*n*=5--6) rats. Data are mean±s.e.m. In **a**, \**P*\<0.05, \*\**P*\<0.01 for Bacteroidetes, ^\#^*P*\<0.05 for Firmicutes and ^†^*P*\<0.05 for Proteobacteria. In **b**--**g**, \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 versus sham in respective intestinal segments based on nonparametric Kruskal--Wallis test with Dunn's multiple comparison analysis.](ismej201770f3){#fig3}

![Ileal microbiota transplant. (**a**) Bacterial diversity as shown by diversity box plots obtained from alpha rarefaction measured by observed species. Data are shown as box and whiskers plots, indicating the median (thick line in the box), the 25th--75th percentile range (boxes) and the 1st--99th percentile range (whiskers). (**b**) Principal coordinate analysis (PCoA) plot using unweighted UniFrac distances of gut microbial communities obtained from sham and RYGB donors (*n*=2) and ileum and cecum of mice (*n*=9) colonized with ileal microbiota from sham-operated or RYGB-treated fa/fa rats. Symbols represent data from individual rat donors or mouse recipients. (**c**) DNA copies of total bacteria per gram contents in the ileum and cecum of mice (*n*=9) colonized with ileal microbiota from sham-operated or RYGB-treated fa/fa rats. (**d**) Oral glucose tolerance test curves and (**e**) fat percentage gain in mice (*n*=9) colonized with ileal microbiota from sham-operated or RYGB-treated fa/fa rats. Data are mean±s.e.m. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 as indicated or versus sham recipient.](ismej201770f4){#fig4}

![Cecal microbiota transplant. (**a**) Bacterial diversity as shown by diversity box plots obtained from alpha rarefaction measured by observed species. Data are shown as box and whiskers plots, indicating the median (thick line in the box), the 25th--75th percentile range (boxes), and the 1st--99th percentile range (whiskers). (**b**) Principal coordinate analysis (PCoA) plot using unweighted UniFrac distances of gut microbial communities obtained from sham and RYGB donors (*n*=2) and ileum and cecum of mice (*n*=9) colonized with cecal microbiota from sham-operated and RYGB-treated rats. Symbols represent data from individual rat donors and mouse recipients. (**c**) DNA copies of total bacteria per gram contents in the ileal and cecal microbiota of mice (*n*=9) colonized with cecal microbiota from sham-operated and RYGB-treated rats. (**d**) Oral glucose tolerance test curves and (**e**) fat percentage gain in mice (*n*=9) colonized with cecal microbiota from sham or RYGB rats. Data are mean±s.e.m. \**P*\<0.05, \*\**P*\<0.01 as indicated or versus RYGB recipient.](ismej201770f5){#fig5}
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